Status:
RECRUITING
Clinical Study of GPA33-specific PET/CT for the Diagnosis of Colorectal Cancer
Lead Sponsor:
Huashan Hospital
Conditions:
Positron-Emission Tomography
Colorectal Neoplasms
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
In this study, we will first investigate the imaging safety and feasibility of \[68Ga\]Ga-NOTA-WWH347 and \[18F\]F-H3RESCA-WWH347 PET/CT in patients with primary and/or metastatic colorectal cancers. ...
Eligibility Criteria
Inclusion
- Be between 18 and 65 years of age and of either sex.
- Patients with colorectal cancer confirmed by puncture or surgical pathology.
- Written informed consent signed by the subject or legal guardian or caregiver.
- Willingness and ability to cooperate with all programs of this study.
Exclusion
- Severe hepatic or renal insufficiency;
- Targeted therapy before radiotherapy or PET/CT scan. Renal function: serum creatinine less than or equal to the upper limit of the normal range;
- Liver function: bilirubin, AST(SGOT)/ALT(SGPT) less than or equal to the upper limit of the normal range.
- History of serious surgery in the last month.
- Those who have participated in other clinical trials during the same period.
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06203587
Start Date
December 1 2023
End Date
December 1 2024
Last Update
February 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Huashan Hospital
Shanghai, China